Kidney Disease

Biopharmaceuticals
Kidney Disease
Market Movers
Pharmaceuticals

DiaMedica Therapeutics Inc. (DMAC): Advancing Kidney Care Innovation

DiaMedica Therapeutics Inc. (DMAC) is a biotechnology company that focuses on developing innovative treatments for neurological and kidney diseases. With a strong emphasis on unmet medical needs, DiaMedica is working to bring transformative solutions to patients who currently have limited options. Its flagship product, DM199, is a recombinant form of the KLK1 protein, aimed at […]

Read More
HeathCare
Kidney Disease
Liver Disease
Market Movers

Travere Therapeutics, Inc. (TVTX): New Hope for Rare Kidney Disorders

Featured Content Travere Therapeutics, Inc. (TVTX) is a biopharmaceutical company focused on developing and delivering therapies for rare and underserved diseases. Travere’s mission centers on advancing treatments for patients with serious and often overlooked conditions, primarily in the areas of nephrology (kidney diseases) and hepatology (liver diseases). The company’s pipeline includes innovative therapies aimed at […]

Read More
© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.